Nippon India Nifty Pharma ETF
NAV · Regular-Growth
As of — · AMFI
Consistency
Steady
positive in 3 of 5 years
1Y return
+19.5%
3Y CAGR
+20.5%
5Y CAGR
+13.9%
AUM
—
fund size
Expense
—
direct plan
Volatility 3Y
16.0%
3Y std dev
Go deeper on Nippon India Nifty Pharma ETF
Two data-only views, computed from this fund's real NAV history — no projections.
In plain English
Long-run track record: about 13.9% CAGR over 5 years. Worst historical drawdown: -21% in Mar 2023, recovered in 5 months.
Auto-generated from holdings, returns and risk data. No paid placement, no copy-pasted boilerplate.
NAV history
Showing Regular · Growth · INF204KC1089
NAV (Direct-Growth)
₹27.1122
Last 1Y
+19.49%
Drawdown stories
The crashes you should know about — and how long the fund took to recover.
Mar 2023
-20.9%Peak ₹14.85 on 4 Oct 2021 → trough ₹11.74 on 13 Mar 2023 (18 months down).
Feb 2025
-16.6%Peak ₹24.25 on 9 Oct 2024 → trough ₹20.23 on 28 Feb 2025 (5 months down).
Computed from the full NAV history. We show drawdowns deeper than 10%, sorted by depth.
Performance
Returns for various periods, with category average and peer rank.
Available plans & options
Click a plan to see its NAV and chart above. Direct plans have lower expense ratios than Regular — same portfolio, more of the return stays with you.
NEW
See your SIP through Indian market history
Pick a fund and a start year — get a 60-second cinematic replay of every crash, boom, and headline with your money in it. Real NAV data, no “assumed 12%” lies.
Try Wealth Time MachineAI · Free
Find what's really inside your funds
Upload your CAS PDF — get instant stock concentration, hidden fund overlap, sector risk, and 3 key insights, written by AI in plain English.
Run Portfolio X-Ray